المؤلفون: Italiano, Antoine, Cassier, Philippe A., Lin, Chia-Chi, Alanko, Tuomo, Peltola, Katriina J., Gazzah, Anas, Shiah, Her-Shyong, Calvo, Emiliano, Cervantes, Andrés, Roda, Desamparados, Tosi, Diego, Gao, Bo, Millward, Michael, Warburton, Lydia, Tanner, Minna, Englert, Stefan, Lambert, Stacie, Parikh, Apurvasena, Afar, Daniel E., Vosganian, Gregory, Moreno, Victor

المساهمون: HUS Comprehensive Cancer Center, Department of Oncology

مصطلحات موضوعية: Budigalimab, Head and neck squamous cell cancer, Non-small cell lung cancer, PD-1 inhibitor, Cancers

وصف الملف: application/pdf

Relation: AbbVie and the authors thank the patients who participated in this clinical trial, the study coordinators, and support staff. We would like to acknowledge James P. Sheridan (Drug Metabolism Pharmacokinetics & Bioanalysis Department, AbbVie) for performing the preclinical and clinical pharmacokinetic studies, and Fiona Harding (Oncology Discovery, AbbVie) for creating, selecting, and validating the ABBV-181 antibody and filing the in vitro/in vivo IND supporting reports, including summaries of the preclinical activity of ABBV-181. Biomarker sample testing was performed by Covance, Princeton, NJ (flow cytometry), Mosaic Laboratories, Lake Forest, CA (immunohistochemistry), and Myriad RBM, Austin, TX (cytokine testing). This study was funded by AbbVie Inc., North Chicago, IL, USA. Medical writing support was provided by Joanne Franklin, PhD, CMPP, Aptitude Health, The Hague, the Netherlands, funded by AbbVie. AbbVie and the authors thank the patients who participated in this clinical trial, the study coordinators, and support staff. We would like to acknowledge James P. Sheridan (Drug Metabolism Pharmacokinetics & Bioanalysis Department, AbbVie) for performing the preclinical and clinical pharmacokinetic studies, and Fiona Harding (Oncology Discovery, AbbVie) for creating, selecting, and validating the ABBV-181 antibody and filing the in vitro/in vivo IND supporting reports, including summaries of the preclinical activity of ABBV-181. Biomarker sample testing was performed by Covance, Princeton, NJ (flow cytometry), Mosaic Laboratories, Lake Forest, CA (immunohistochemistry), and Myriad RBM, Austin, TX (cytokine testing). This study was funded by AbbVie Inc., North Chicago, IL, USA. Medical writing support was provided by Joanne Franklin, PhD, CMPP, Aptitude Health, The Hague, the Netherlands, funded by AbbVie. Antoine Italiano: Consulting/advisory role: Roche, Daiichi Sankyo, Immune Design, Epizyme, Bayer, Lilly; honoraria: Bayer, Daiichi Sankyo, Lilly, Epizyme, Novartis, Roche; research funding: Roche, Bayer, AstraZeneca/MedImmune, PharmaMar, MSD Oncology, Merck Serono. Philippe A. Cassier: Honoraria: Novartis, Roche/Genentech, Blueprint Medicines, Amgen; research funding: Novartis, Roche/Genentech, Lilly, Blueprint Medicines, Bayer, AstraZeneca, Celgene, Plexxikon, AbbVie, Bristol-Myers Squibb, Merck Serono, Merck Sharp & Dohme; Consultancy/advisory role: Merck Serono, Roche/Genentech. Chia-Chi Lin: Consulting/advisory role: Novartis, Boehringer Ingelheim, Blueprint Medicines; travel/accommodations/expenses: Lilly, Daiichi Sankyo, BeiGene, Novartis; honoraria: Novartis, Roche, Daiichi Sankyo. Tuomo Alanko: Consulting/advisory role: Bayer, Baxalta/Shire, BMS, Celgene, Eli Lilly, MSD, Nordic Drugs, Roche, Kaiku Health; research funding: AbbVie, Bayer, Boehringer Ingelheim, BMS, Debiopharm, Eli Lilly, Incyte, MSD, Pfizer, Roche; travel/accommodations/expenses: Baxalta/Shire, BMS, MSD, Pfizer, Roche. Katriina J. Peltola: Consulting/advisory role: Orion Pharma, BMS, MSD, Novartis, Pfizer, Ipsen, Roche, Varian; stockholder: Faron Pharmaceuticals; speakers’ bureau: BMS, Pfizer, MSD; expert testimony: Ipsen; travel/accommodations/expenses: Roche, BMS; research funding: AbbVie, Bayer, BMS, MSD, Roche, Exelixis, Orion Pharma, Eisai, Novartis. Anas Gazzah: Travel, accommodations, congress registration expenses: Boehringer Ingelheim, Novartis, Pfizer, Roche; consultant/expert role: Novartis; principal/sub-investigator of clinical trials: Aduro Biotech, Agios Pharmaceuticals, Amgen, Argen-X BVBA, Arno Therapeutics, Astex Pharmaceuticals, AstraZeneca, Aveo, Bayer HealthCare Ag, BBB Technologies BV, BeiGene, BioAlliance Pharma, BioNTech AG, Blueprint Medicines, Boehringer Ingelheim, Bristol-Myers Squibb, Ca, Celgene Corporation, Chugai Pharmaceutical Co., Clovis Oncology, Daiichi Sankyo, Debiopharm SA, Eisai, Exelixis, Forma, GamaMabs, Genentech, Inc., Gilead Sciences, Inc, GlaxoSmithKline, Glenmark Pharmaceuticals, H3 Biomedicine, Inc, F. Hoffmann-La Roche AG, Incyte Corporation, Innate Pharma, Servier IRIS, Janssen, Kura Oncology, Kyowa Kirin Pharmaceutical Development, Lilly, Loxo Oncology, Lytix Biopharma AS, MedImmune, Menarini Ricerche, Merck Sharp & Dohme Chibret, Merrimack Pharmaceuticals, Merus, Millennium Pharmaceuticals, Nanobiotix, Nektar Therapeutics, Novartis Pharma, Octimet Oncology NV, OncoEthix, OncoMed, Oncopeptides, Onyx Therapeutics, Orion Pharma, Oryzon Genomics, Pfizer, PharmaMar, Pierre Fabre, Rigontec GmbH, Roche, Sanofi Aventis, Sierra Oncology, Taiho Pharma, Tesaro, Inc, Tioma Therapeutics, Inc., Xencor; research grants: AstraZeneca, BMS, Boehringer Ingelheim, Janssen Cilag, Merck, Novartis, Pfizer, Roche, Sanofi; nonfinancial support (drug supplied): AstraZeneca, Bayer, BMS, Boehringer Ingelheim, Johnson & Johnson, Lilly, MedImmune, Merck, NH TherAGuix, Pfizer, Roche. Her-Shyong Shiah: The author declares no potential conflicts of interest. Emiliano Calvo: Consulting/advisory role: Novartis, Nanobiotix, Janssen-Cilag, PsiOxus, Seattle Genetics, EUSA Pharma, AbbVie, Celgene, AstraZeneca, Guidepoint Global, Roche/Genentech, GLG, Pfizer, Servier, amcure; speakers’ bureau: Novartis; research funding: AstraZeneca, BeiGene, Novartis, START; travel/accommodations/expenses reimbursement: Roche/Genentech; honoraria: HM Hospitales Group; stock/ownership interests: START, Oncoart Associated, International Cancer Consultants; president and founder of Foundation INTHEOS . Andrés Cervantes: Institutional research funding: AbbVie, Genentech, Merck Serono, BMS, MSD, Roche, BeiGene, Bayer, Servier, Lilly, Novartis, Takeda, Astellas, FibroGen; advisory board or speaker fees: Merck Serono, Roche, Bayer, Servier, Pierre Fabre. Desamparados Roda: The author declares no potential conflicts of interest. Diego Tosi: Consulting/advisory role: BioMarin (immediate family member); research funding: Novartis, Astellas, Janssen; patent pending on a new drug combination for prostate cancer treatment; travel/accommodations/expenses: Janssen, Pfizer, Astellas Pharma; immediate family member had travel/accommodations/expenses from Nutricia and Amicus. Bo Gao: Consulting/advisory role: MSD. Michael Millward: Consulting/advisory role: Merck Sharp & Dohme, Bristol-Myers Squibb, AstraZeneca, Roche, Pfizer, Takeda, Novartis; conference travel/support: Merck Sharp & Dohme, Bristol-Myers Squibb, AstraZeneca, Roche. Lydia Warburton: Travel/accommodations/expenses: MSD, Merck. Minna Tanner: Consulting/advisory role: Roche, Novartis, Pfizer; speakers’ bureau: Roche, Novartis, Pfizer, Amgen. Gregory Vosganian: Former employee of AbbVie and may own stock. Stefan Englert, Stacie Lambert, Apurvasena Parikh, Daniel E. Afar: AbbVie employees and may own stock. Victor Moreno: Consulting fees: Merck, BMS, Janssen, Pieris; travel/accommodations: Regeneron/Sanofi; presentations: Nanobiotix; educational grant: Medscape/Bayer.; Italiano , A , Cassier , P A , Lin , C-C , Alanko , T , Peltola , K J , Gazzah , A , Shiah , H-S , Calvo , E , Cervantes , A , Roda , D , Tosi , D , Gao , B , Millward , M , Warburton , L , Tanner , M , Englert , S , Lambert , S , Parikh , A , Afar , D E , Vosganian , G & Moreno , V 2022 , ' First-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma ' , Cancer Immunology, Immunotherapy , vol. 71 , no. 2 , pp. 417-431 . https://doi.org/10.1007/s00262-021-02973-w; http://hdl.handle.net/10138/354706; 82232dae-2a73-44eb-98d3-0e87d81835e0; 85109344549

الاتاحة: http://hdl.handle.net/10138/354706

المؤلفون: Yang, James Chih-Hsin, Su, Wu-Chou, Chiu, Chao-Hua, Shiah, Her-Shyong, Lee, Kang-Yun, Hsia, Te-Chun, Uno, Makiko, Crawford, Nigel, Terakawa, Hiroshi, Chen, Wen-Chi, Takayama, Gensuke, Hsu, Ching, Hong, Ying, Saintilien, Carline, McGill, Joseph, Chang, Gee-Chen

المصدر: Investigational New Drugs ; volume 41, issue 2, page 306-316 ; ISSN 0167-6997 1573-0646

الاتاحة: http://dx.doi.org/10.1007/s10637-023-01341-y
https://link.springer.com/content/pdf/10.1007/s10637-023-01341-y.pdf
https://link.springer.com/article/10.1007/s10637-023-01341-y/fulltext.html

المؤلفون: Dai, Ming-Shen, Chao, Ta-Chung, Chiu, Chang-Fang, Lu, Yen-Shen, Shiah, Her-Shyong, Jackson, Christopher G. C. A., Hung, Noelyn, Zhi, Jianguo, Cutler, David L., Kwan, Rudolf, Kramer, Douglas, Chan, Wing-Kai, Qin, Albert, Tseng, Kuan-Chiao, Hung, Cheung Tak, Chao, Tsu-Yi

المساهمون: PharmaEssentia Corporation, Athenex

المصدر: Therapeutic Advances in Medical Oncology ; volume 15 ; ISSN 1758-8359 1758-8359

الاتاحة: https://doi.org/10.1177/17588359231183680
https://journals.sagepub.com/doi/pdf/10.1177/17588359231183680
https://journals.sagepub.com/doi/full-xml/10.1177/17588359231183680

المؤلفون: Shiah, Her-Shyong, Lee, Chia-Jung, Lee, Fang-Yu, Tseng, Sung-Hui, Chen, Shih-Han, Wang, Ching-Chiung

المصدر: Frontiers in Pharmacology ; volume 14 ; ISSN 1663-9812

الاتاحة: http://dx.doi.org/10.3389/fphar.2023.1106030
https://www.frontiersin.org/articles/10.3389/fphar.2023.1106030/full

المؤلفون: Chiang, Cho-Han, Chiang, Cho-Hung, Ma, Kevin Sheng-Kai, Hsia, Yuan Ping, Lee, Yu-wen, Wu, Han-Ru, Chiang, Cho-Hsien, Peng, Chun-Yu, Wei, James Cheng-Chung, Shiah, Her-Shyong, Peng, Cheng-Ming, Neilan, Tomas G

المساهمون: National Institutes of Health, National Heart, Lung, Blood Institute

المصدر: Japanese Journal of Clinical Oncology ; volume 52, issue 12, page 1389-1398 ; ISSN 1465-3621

الاتاحة: https://doi.org/10.1093/jjco/hyac150
https://academic.oup.com/jjco/article-pdf/52/12/1389/47588619/hyac150.pdf

المؤلفون: Lu, Shun, Wang, Qiming, Zhang, Guojun, Dong, Xiaorong, Yang, Cheng-Ta, Song, Yong, Chang, Gee-Chen, Lu, You, Pan, Hongming, Chiu, Chao-Hua, Wang, Zhehai, Feng, Jifeng, Zhou, Jianying, Xu, Xingxiang, Guo, Renhua, Chen, Jianhua, Yang, Haihua, Chen, Yuan, Yu, Zhuang, Shiah, Her-Shyong, Wang, Chin-Chou, Yang, Nong, Fang, Jian, Wang, Ping, Wang, Kai, Hu, Yanping, He, Jianxing, Wang, Ziping, Shi, Jianhua, Chen, Shaoshui, Wu, Qiong, Sun, Changan, Li, Chuan, Wei, Hongying, Cheng, Ying, Su, Wu-Chou, Hsia, Te-Chun, Cui, Jiuwei, Sun, Yuping, Ou, Sai-Hong Ignatius, Zhu, Viola W., Chih-Hsin Yang, James

المصدر: Journal of Thoracic Oncology ; volume 17, issue 3, page 411-422 ; ISSN 1556-0864

الاتاحة: http://dx.doi.org/10.1016/j.jtho.2021.10.024
https://api.elsevier.com/content/article/PII:S1556086421033232?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1556086421033232?httpAccept=text/plain

المؤلفون: Chiang, Cho‐Han, Chiang, Cho‐Hung, Hsia, Yuan Ping, Jaroenlapnopparat, Aunchalee, Horng, Chuan‐Sheng, Wong, Kit Yee, Wang, Shih‐Syuan, Chang, Yu‐Cheng, Chen, Brian Shiian, Luan, Yu‐Ze, Wang, Chun‐Hao, Neilan, Tomas G., Chiang, Cho‐Hsien, Peng, Cheng‐Ming, Shiah, Her‐Shyong

المصدر: Journal of Gastroenterology and Hepatology ; volume 39, issue 5, page 902-907 ; ISSN 0815-9319 1440-1746

الاتاحة: http://dx.doi.org/10.1111/jgh.16498
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.16498

المؤلفون: Italiano, Antoine, Cassier, Philippe A., Lin, Chia Chi, Alanko, Tuomo, Peltola, Katriina J., Gazzah, Anas, Shiah, Her Shyong, Calvo, Emiliano, Cervantes, Andrés, Roda, Desamparados, Tosi, Diego, Gao, Bo, Millward, Michael, Warburton, Lydia, Tanner, Minna, Englert, Stefan, Lambert, Stacie, Parikh, Apurvasena, Afar, Daniel E., Vosganian, Gregory, Moreno, Victor

المساهمون: Tampere University, Department of Oncology

مصطلحات موضوعية: 3122 Cancers

وصف الملف: fulltext

Relation: Cancer Immunology, Immunotherapy; https://trepo.tuni.fi/handle/10024/133491

الاتاحة: https://trepo.tuni.fi/handle/10024/133491
https://doi.org/10.1007/s00262-021-02973-w

المؤلفون: Tsai, Hui-Jen, Shiah, Her-Shyong, Chang, Jang-Yang, Su, Wu-Chou, Chiang, Nai-Jung, Chen, Li-Tzong

المصدر: Scientific Reports ; volume 11, issue 1 ; ISSN 2045-2322

الاتاحة: http://dx.doi.org/10.1038/s41598-021-84279-6
https://www.nature.com/articles/s41598-021-84279-6.pdf
https://www.nature.com/articles/s41598-021-84279-6

المؤلفون: Lee, Hsin-Lun, Chiou, Jeng-Fong, Wang, Peng-Yuan, Lu, Long-Sheng, Shen, Chia-Ning, Hsu, Han-Lin, Burnouf, Thierry, Ting, Lai-Lei, Chou, Pai-Chien, Chung, Chi-Li, Lee, Kai-Ling, Shiah, Her-Shyong, Liu, Yen-Lin, Chen, Yin-Ju

المساهمون: Swinburne University of Technology

المصدر: Cancers, Vol. 12, no. 11 (Nov 2020), 3394

Relation: http://hdl.handle.net/1959.3/458972; https://doi.org/10.3390/cancers12113394

الاتاحة: http://hdl.handle.net/1959.3/458972
https://doi.org/10.3390/cancers12113394

المؤلفون: de Bono, Johann, Lin, Chia-Chi, Chen, Li-Tzong, Corral, Jesus, Michalarea, Vasiliki, Rihawi, Karim, Ong, Michael, Lee, Jih-Hsiang, Hsu, Chih-Hung, Yang, James Chih-Hsin, Shiah, Her-Shyong, Yen, Chia-Jui, Anthoney, Alan, Jove, Maria, Buschke, Susanne, Fuertig, René, Schmid, Ulrike, Goeldner, Rainer-Georg, Strelkowa, Natalja, Huang, Dennis Chin-Lun, Bogenrieder, Thomas, Twelves, Chris, Cheng, Ann-Lii

المساهمون: Boehringer Ingelheim

المصدر: British Journal of Cancer ; volume 122, issue 9, page 1324-1332 ; ISSN 0007-0920 1532-1827

الاتاحة: http://dx.doi.org/10.1038/s41416-020-0774-1
http://www.nature.com/articles/s41416-020-0774-1.pdf
http://www.nature.com/articles/s41416-020-0774-1

المؤلفون: Changou, Chun A., Shiah, Her-Shyong, Chen, Li-Tzong, Liu, Servina, Luh, Frank, Liu, Shwu-Huey, Cheng, Yung-Chi, Yen, Yun

المصدر: The Oncologist ; volume 26, issue 3, page e367-e373 ; ISSN 1083-7159 1549-490X

الاتاحة: https://doi.org/10.1002/onco.13582
https://onlinelibrary.wiley.com/doi/pdf/10.1002/onco.13582
https://onlinelibrary.wiley.com/doi/full-xml/10.1002/onco.13582
https://academic.oup.com/oncolo/article-pdf/26/3/e367/41923884/oncolo_26_3_e367.pdf

المؤلفون: Shiah, Her-Shyong, Chiang, Nai-Jung, Lin, Chia-Chi, Yen, Chia-Jui, Tsai, Hui-Jen, Wu, Shang-Yin, Su, Wu-Chou, Chang, Kwang-Yu, Wang, Ching-Chiung, Chang, Jang-Yang, Chen, Li-Tzong

المصدر: The Oncologist ; volume 26, issue 4, page e567-e579 ; ISSN 1083-7159 1549-490X

الاتاحة: http://dx.doi.org/10.1002/onco.13612
https://onlinelibrary.wiley.com/doi/pdf/10.1002/onco.13612
https://onlinelibrary.wiley.com/doi/full-xml/10.1002/onco.13612
https://academic.oup.com/oncolo/article-pdf/26/4/e567/41923808/oncolo_26_4_e567.pdf

المؤلفون: Yang, James Chih-Hsin, Camidge, D. Ross, Yang, Cheng-Ta, Zhou, Jianying, Guo, Renhua, Chiu, Chao-Hua, Chang, Gee-Chen, Shiah, Her-Shyong, Chen, Yuan, Wang, Chin-Chou, Berz, David, Su, Wu-Chou, Yang, Nong, Wang, Ziping, Fang, Jian, Chen, Jianhua, Nikolinakos, Petros, Lu, You, Pan, Hongming, Maniam, Ajit, Bazhenova, Lyudmila, Shirai, Keisuke, Jahanzeb, Mohammad, Willis, Maurice, Masood, Nehal, Chowhan, Naveed, Hsia, Te-Chun, Jian, Hong, Lu, Shun

المساهمون: West China Hospital of Sichuan University

المصدر: Journal of Thoracic Oncology ; volume 15, issue 12, page 1907-1918 ; ISSN 1556-0864

الاتاحة: http://dx.doi.org/10.1016/j.jtho.2020.09.001
https://api.elsevier.com/content/article/PII:S1556086420307140?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1556086420307140?httpAccept=text/plain

المؤلفون: Chiang, Cho-Han, Chiang, Cho-Hung, Chiang, Cho-Hsien, Ma, Kevin Sheng-Kai, Peng, Chun-Yu, Hsia, Yuan Ping, Horng, Chuan-Sheng, Chen, Cheng-Ying, Chang, Yu-Cheng, See, XinYa, Chen, Yuan-Jen, Wang, Shih-Syuan, Suero-Abreu, Giselle A, Peterson, L R, Thavendiranathan, Paaladinesh, Armand, Philippe, Peng, Cheng-Ming, Shiah, Her-Shyong, Neilan, Tomas G

المصدر: Rochester Regional Health authored publications and proceedings

مصطلحات موضوعية: Heart failure, Medicine and Health Sciences

Relation: https://scholar.rochesterregional.org/rrhpubs/1695; https://doi.org/10.1136/heartjnl-2022-321545

الاتاحة: https://scholar.rochesterregional.org/rrhpubs/1695
https://doi.org/10.1136/heartjnl-2022-321545

المؤلفون: Chiang, Cho Han, CHIANG, CHO HUNG, Chiang, Cho Hsien, Ma, Kevin, Peng, Chun-Yu, yuanping, HSIA, Horng, Chuan-Sheng, CHEN, CHENG-YING, Chang, Yu-Cheng, See, Xin Ya, Chen, Yuan-Jen, Wang, Shih-Syuan, Suero Abreu, Giselle A, Peterson, Linda R, Thavendiranathan, Paaladinesh, Armand, Philippe, Peng, Cheng-Ming, Shiah, Her-Shyong, Neilan, Tomas G

المصدر: Circulation ; volume 146, issue Suppl_1 ; ISSN 0009-7322 1524-4539

الاتاحة: http://dx.doi.org/10.1161/circ.146.suppl_1.12767

المؤلفون: Huang,Guan-Cheng, Chen,Shih-Yu, Tsai,Po-Wei, Ganzon,Jerome G., Lee,Chia-Jung, Shiah,Her-Shyong, Wang,Ching-Chiung

مصطلحات موضوعية: Drug Design, Development and Therapy

وصف الملف: text/html

Relation: https://www.dovepress.com/effects-of-dang-gui-bu-xue-tang-an-herbal-decoction-on-iron-uptake-in--peer-reviewed-fulltext-article-DDDT

الاتاحة: https://www.dovepress.com/effects-of-dang-gui-bu-xue-tang-an-herbal-decoction-on-iron-uptake-in--peer-reviewed-fulltext-article-DDDT

المؤلفون: Wang, Ching-Chiung, Huang, Guan-Cheng, Chen, Shih-Yu, Tsai, Po-Wei, Lee, Chia-Jung, Ganzon, Jerome G., Shiah, Her-Shyong

المصدر: Drug Design, Development and Therapy ; page 949 ; ISSN 1177-8881

الاتاحة: http://dx.doi.org/10.2147/dddt.s94309
https://www.dovepress.com/getfile.php?fileID=29233

المؤلفون: Ho, Chin-Beng, Tsai, Jo-Ting, Chen, Chun-You, Shiah, Her-Shyong, Chen, Hsuan-Yu, Ting, Lai-Lei, Kuo, Chia-Chun, Lai, I-Chun, Lai, Hsin-Yi, Chung, Chi-Li, Lee, Kai-Ling, Tzeng, Huey-En, Lee, Kuen-Haur, Lee, Hsin-Lun, Chen, Shang-Wen, Chiou, Jeng-Fong

المصدر: Diagnostics (2075-4418); May2023, Vol. 13 Issue 9, p1597, 11p

مصطلحات موضوعية: STEREOTACTIC radiotherapy, PROGNOSIS, LUNG tumors, RADIATION pneumonitis, PROGRESSION-free survival

المؤلفون: Chiang, Cho-Han, Chiang, Cho-Hung, Ma, Kevin Sheng-Kai, Hsia, Yuan Ping, Lee, Yu-wen, Wu, Han-Ru, Chiang, Cho-Hsien, Peng, Chun-Yu, Wei, James Cheng-Chung, Shiah, Her-Shyong, Peng, Cheng-Ming, Neilan, Tomas G

المصدر: Japanese Journal of Clinical Oncology; Dec2022, Vol. 52 Issue 12, p1389-1398, 10p